These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36547144)
1. The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Al Khaldi M; Fellouah M; Drolet P; Côté J; Trilling B; Brind'Amour A; Dugas A; Tremblay JF; Fortin S; De Guerké L; Auclair MH; Dubé P; Soucisse M; Sideris L Curr Oncol; 2022 Nov; 29(12):9314-9324. PubMed ID: 36547144 [TBL] [Abstract][Full Text] [Related]
2. Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer. van Vugt JL; Braam HJ; van Oudheusden TR; Vestering A; Bollen TL; Wiezer MJ; de Hingh IH; van Ramshorst B; Boerma D Ann Surg Oncol; 2015 Oct; 22(11):3625-31. PubMed ID: 25672564 [TBL] [Abstract][Full Text] [Related]
3. Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer. Chemama S; Bayar MA; Lanoy E; Ammari S; Stoclin A; Goéré D; Elias D; Raynard B; Antoun S Ann Surg Oncol; 2016 Nov; 23(12):3891-3898. PubMed ID: 27352205 [TBL] [Abstract][Full Text] [Related]
4. Overall survival of pseudomyxoma peritonei and peritoneal mesothelioma patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be predicted by computed tomography quantified sarcopenia. Galan A; Rousset P; Mercier F; Képénékian V; Valette PJ; Glehen O; Passot G Eur J Surg Oncol; 2018 Nov; 44(11):1818-1823. PubMed ID: 30143249 [TBL] [Abstract][Full Text] [Related]
5. The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience. Agalar C; Sokmen S; Arslan C; Altay C; Basara I; Canda AE; Obuz F Tech Coloproctol; 2020 Apr; 24(4):301-308. PubMed ID: 32080800 [TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review. Chow FC; Yip J; Foo DC; Wei R; Choi HK; Ng KK; Lo OS Asian J Surg; 2021 Jan; 44(1):221-228. PubMed ID: 32605790 [TBL] [Abstract][Full Text] [Related]
7. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience. Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828 [TBL] [Abstract][Full Text] [Related]
8. High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy. Zhou S; Feng Q; Zhang J; Zhou H; Jiang Z; Liu Z; Zheng Z; Chen H; Wang Z; Liang J; Pei W; Liu Q; Zhou Z; Wang X BMC Cancer; 2021 Jan; 21(1):41. PubMed ID: 33413223 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy]. Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167 [No Abstract] [Full Text] [Related]
10. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. Lee L; Alie-Cusson F; Dubé P; Sideris L J Surg Oncol; 2017 Aug; 116(2):236-243. PubMed ID: 28409831 [TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: a 13 years-retrospective monocentric study. Livin M; Leonard D; Bachmann R; Remue C; Barbois S; Cotte E; Van Den Eynde M; De Cuyper A; Sinapi I; Van Maanen A; Kartheuser A Acta Gastroenterol Belg; 2022; 85(4):573-579. PubMed ID: 36566366 [TBL] [Abstract][Full Text] [Related]
12. Preoperative nutritional risk assessment in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for colorectal carcinomatosis. Banaste N; Rousset P; Mercier F; Rieussec C; Valette PJ; Glehen O; Passot G Int J Hyperthermia; 2018 Aug; 34(5):589-594. PubMed ID: 28828897 [TBL] [Abstract][Full Text] [Related]
13. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches. Chang SC; Fingerhut A; Chen WT Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Laparoscopy in Patients With Peritoneal Carcinomatosis Is Safe and Does Not Delay Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. Hanna DN; Ghani MO; Hermina A; Mina A; Bailey CE; Idrees K; Magge D Am Surg; 2022 Apr; 88(4):698-703. PubMed ID: 34732056 [TBL] [Abstract][Full Text] [Related]
15. The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases. van der Werf LR; Wassenaar E; de Niet A; Lalezari F; Braam HJ; van Ramshorst B; Nederend J; de Hingh IHJT; Kok NFM; Aalbers AGJ Eur J Surg Oncol; 2019 Mar; 45(3):376-382. PubMed ID: 30414704 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of elderly patients with peritoneal metastases of colorectal origin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Weksler Y; Hoffman A; Green E; Kyzer M; Nevo N; Gerstenhaber F; Greenberg R; Klausner JM; Gutman M; Lahat G; Berger Y; Geva R; Nizri E Surg Oncol; 2022 Sep; 44():101848. PubMed ID: 36126349 [TBL] [Abstract][Full Text] [Related]
17. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study. Flood MP; Waters PS; Kelly ME; Shields C; Conneely J; Ramsay R; Michael M; Loveday B; Warrier SK; Mulsow J; Heriot AG Surg Oncol; 2021 Jun; 37():101553. PubMed ID: 33839444 [TBL] [Abstract][Full Text] [Related]
18. The impact of postoperative complications following cytoreductive surgery combined with oxaliplatin based heated intraperitoneal chemotherapy. Verwaal VJ; Funder JA; Sørensen MM; Iversen LH Eur J Surg Oncol; 2022 Jan; 48(1):183-187. PubMed ID: 34474946 [TBL] [Abstract][Full Text] [Related]
19. Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)? Zhou S; Feng Q; Zhang J; Zhou H; Jiang Z; Liang J; Pei W; Liu Q; Zhou Z; Wang X Clin Interv Aging; 2021; 16():559-568. PubMed ID: 33833505 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy. Zhou S; Jiang Y; Liang J; Pei W; Zhou Z World J Surg Oncol; 2021 May; 19(1):151. PubMed ID: 34001125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]